Synapse Open Synapse
Business

The $15bn ‘viral’ AI start-up changing how American doctors treat patients

Financial Times ·

Founder of OpenEvidence chatbot says two-thirds of US physicians use the ad-powered tool, prompting a debate about patient care

Latest from Financial Times